Updated Interim Data from Phase I Trial of STRO-002 Show Promise in Ovarian Cancer

Encouraging interim data were reported from the ongoing phase I clinical trial of STRO-002 regarding safety and anti-tumor activity results in heavily pre-treated patients with ovarian cancer.

Source: CancerNetwork - April 27, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news